wyniki I półrocze 2025 - komunikat spółki KRKA, TOVARNA ZDRAVIL D.D. (krka) - komunikat ESPI

Komunikat spółki

COMMON REPORT

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		28	/	2025
	Date of issue:		2025-07-10
	Short name of the issuer
	KRKA
	Subject
	Information regarding estimated operating results of the Krka Group for the first half of 2025
	Official market - legal basis
	art. 17. 1 MAR.
	Unofficial market - legal basis
	Contents of the report:
	Based on Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto releases information regarding estimated operating results of the Krka Group for the first half of 2025. See attached document. The notice will be published on the Company's website (www.krka.biz) from 10 July 2025 onwards, for a minimum 5 years.
	Annexes
	File				Description
	Krka Group estimated operating results for H1 2025.pdf				Krka Group estimated operating results for H1 2025

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

6

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2025-07-10	Jože Colarič	President of the Management Board and CEO

Nazwa jednostki:	KRKA, TOVARNA ZDRAVIL D.D.
Nazwa skrócona jednoskti:	KRKA
Adres:	Smarjeska 6, 8501 Nove Mesto
Telefon:	+386 7 331 21 11
Fax:	+386 7 332 15 37
NIP:	nie dotyczy